Actively Recruiting
Phase III Study of More Intensive Peri-Operative Chemotherapy in High-Risk CINSARC Patients with Resectable Soft-Tissue Sarcoma
Led by Institut Bergonié · Updated on 2025-10-02
351
Participants Needed
10
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether adding three extra cycles of doxorubicin-based chemotherapy before surgery can improve outcomes for patients with high-risk CINSARC soft-tissue sarcoma STS that can be removed by surgery. This study compares the standard treatment approach, which involves three cycles of neoadjuvant chemotherapy followed by surgery and possibly radiotherapy, to an intensified regimen of six chemotherapy cycles. The main goal is to see if this intensified treatment helps prevent the cancer from spreading over three years. The trial is a phase III, multicenter, randomized study with two main groups for high-risk patients one receiving the standard three cycles of doxorubicin combined with ifosfamide or dacarbazine every three weeks before surgery, and the other receiving six cycles of the same chemotherapy drugs before surgery. Radiotherapy may be given before or after surgery as decided by the doctors. For low-risk patients, treatment is given based on the doctors choice in a separate observational cohort. Participants will undergo chemotherapy cycles lasting three weeks each, followed by surgery and possible radiotherapy. Throughout the study, researchers will assess cancer progression, survival, treatment response, and safety over a three-year period. Patients will be monitored regularly for disease status and side effects. The total study duration includes a follow-up of at least three years to evaluate metastatic progression-free survival as the primary outcome.
CONDITIONS
Brief Title
Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue Sarcomas
Research Team
A
Antoine ITALIANO, MD, PhD
S
Simone MATHOULIN-PELISSIER, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here